Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications

Schematic representation of the TGF-β signaling pathway. TGFB exerts its action by forming dimers that bind to two copies of type II receptors (TGFBR-II) and two copies of type I receptors (TGFBR-I). Upon binding, TGFBR-I receptors are phosphorylated and activated by TGFBR-II receptors. The activated TGFBR-I receptors then phosphorylate the cytoplasmic transcription factors Smad2 and Smad3, which combine with Smad4 to form a trimer. This resultant complex translocates to the nucleus and regulates target gene expression.
Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications

Publication

Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications. (2023) Laura Giannotti, et al. Genes (Basel). 2023 Sep;14(9):1669. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates TGF-B TGFB ncbigene_synonym TGFB1 7040
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB2 7042
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB3 7043
Homo sapiens Primates TGFBR-II TGFBRII ncbigene_synonym TGFBR2 7048
Homo sapiens Primates Smad4 SMAD4 ncbigene_symbol SMAD4 4089
Homo sapiens Primates Smad3 SMAD3 ncbigene_symbol SMAD3 4088
Homo sapiens Primates Smad2 SMAD2 ncbigene_symbol SMAD2 4087

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID